RxDoctor Payments DataLook up a doctor →

Joseph Boscia, MD

Pulmonary Disease · Spartanburg, SCNPI 1669437257

Payments from drug & device makers

$7,931,361in general payments, 2019–2025

Across 2,232 payments — averaging $3553.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Eli Lilly$2.2M
  • AstraZeneca$1.2M
  • Modernatx, Inc.$898K
  • GSK$820K
  • Boehringer Ingelheim$674K
  • Pfizer$476K
  • plus $1.7M from 54 others
$355,877in research payments, 2019–2025

Across 6 payments — averaging $59,313 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Eli Lilly$356K

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Eli Lilly11$2,220,172
AstraZeneca(2 entities)147$1,179,896
Modernatx, Inc.22$898,111
GSK661$819,637
Boehringer Ingelheim133$673,597
Pfizer33$476,094
Seqirus USA Inc143$332,263
Abbott86$236,167
Mylan Specialty L.p.49$222,607
Verona Pharma, Inc.44$187,236
Amphastar Pharmaceuticals, Inc.3$143,988
CSL Behring13$124,417
Roche Diagnostics Operations, Inc.1$97,931
Novartis8$78,553
Currax Pharmaceuticals LLC21$72,579
Mallinckrodt Hospital Products Inc.60$63,163
Boehringer Ingelheim International GmbH160$26,927
Chiesi USA, Inc.25$25,151
Roche Products Limited3$19,500
Merck12$10,398
Boehringer Ingelheim Pharma GmbH & Co.kg3$10,015
Actelion Pharmaceuticals US, Inc.55$1,645
Viiv Healthcare Company1$1,600
Electromed, Inc.106$1,331
Sanofi54$1,127
United Therapeutics Corporation42$1,029
Regeneron Healthcare Solutions, Inc.45$1,011
Philips North America LLC34$640
Takeda Pharmaceuticals U.S.A., Inc.25$563
Gilead26$499
Amgen31$493
Johnson & Johnson(2 entities)30$441
Sunovion Pharmaceuticals Inc.22$332
Insmed, Inc.21$331
Axsome Therapeutics, Inc.11$234
Grifols USA, LLC14$230
Bayer8$159
ANI Pharmaceuticals, Inc.7$122
Shionogi Inc2$117
Genentech USA, Inc.6$100
Teva Pharmaceuticals USA, Inc.7$90
Inogen, Inc.5$90
Baxter Healthcare3$86
Resmed Corp5$77
Advanced Respiratory, Inc4$65
Portola Pharmaceuticals, LLC3$63
Harmony Biosciences LLC3$53
Jazz Pharmaceuticals Inc.2$52
Hikma Pharmaceuticals USA3$46
Viatris Specialty LLC2$41
Pharming Healthcare, Inc.2$37
Melinta Therapeutics, LLC2$35
Pulmonx Corporation2$33
Exact Sciences1$26
Body Vision Medical Inc.1$23
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)1$22
Lilly USA, LLC1$17
Idorsia Pharmaceuticals US Inc1$15
Nabriva Therapeutics, PLC1$15
Tetraphase Pharmaceuticals, Inc.1$15

How this compares

$7,931,361 in reported general payments places this provider in the 95th percentile of 192 pulmonary disease providers in South Carolina.

See all pulmonary disease providers in South Carolina →

Medicare billing

Part B allowed, 2024
$211,646
Medicare patients
817
Services billed
3,218

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other pulmonary disease in Spartanburg

See the full list for South Carolina →

Where these figures come from

Is this you, or does something look wrong? →